I am a specialist in the Inflammatory Bowel Diseases (IBD), Ulcerative Coltitis and Crohn's Disease @ Mount Sinai
Joined August 2010
- Tweets 710
- Following 1,361
- Followers 611
- Likes 520
151 Photos and videos
Adam Steinlauf retweeted
We’re proud to celebrate the recipients of the Cullman Family Award for Excellence in Provider Communication at Mount Sinai. Congratulations to all honorees for ranking in the top 5% nationwide for outstanding, compassionate communication! #MountSinaiProud
3
8
1,117
3 Nov 2024
Had a great time practicing with Tom Ullman for our reunion performance at this years CCF Gala.
1
1
13
829
12 Jun 2024
Our paper on the beneficial effects of upadacitinib on quality of life in patients with Crohn’s Disease.
2
15
1,096
16 Apr 2024
Great evening with colleagues and fellows!!
Springtime at @MountSinaiGI means another round of Faculty Dining Series! (No bowel prep required.)
@Danny_WongMD @Typical_Brian @RababOun @HyderSaidMD @Adams1002 @ManasiAgrawalMD @brownbrij76 @jdclaytor @SalamBeahMD @JellyanaPeraza
1
5
746
23 Feb 2024
Proud to be promoted to Professor of Medicine at Icahn School of Medicine, Mount Sinai Health System.
8
2
40
2,620
14 Feb 2024
Our article on biosimilars for the ACG FDA-Related Matters Committee.
In the 📕#RedJournal:
Overview of Biosimilars in Inflammatory Bowel Diseases
Feagins, et al.
👉 bit.ly/48dYj8n
@GimdGold @Adams1002
4
6
2,211
Adam Steinlauf retweeted
In the 📕#RedJournal:
Overview of Biosimilars in Inflammatory Bowel Diseases
Feagins, et al.
👉 bit.ly/48dYj8n
@GimdGold @Adams1002
7
20
6,656
Adam Steinlauf retweeted
14 Feb 2024
If you suffer from IBD and your disease is difficult to control, or if you simply want to be involved in research that will change how we manage IBD, please feel free to fill out the following questionnaire to see if you qualify for a Mount Sinai trial:
urldefense.proofpoint.com/v2…
2
3
634
Adam Steinlauf retweeted
10 Feb 2024
Are you interested in participating in a clinical trial for Inflammatory Bowel Disease? If so, please fill out the following survey.
urldefense.proofpoint.com/v2…
2
3
514
Adam Steinlauf retweeted
Dr. Marla Dubinsky discusses a study that showed the efficacy of Mirikizumab in patients with ulcerative colitis, highlighting its durability via @medresearchnews, which led to the approval of Mirikizumab by the FDA: mshs.co/3QUEo8Q
@MSHS_IBDCenter @DOMSinaiNYC
4
3
1,521
Adam Steinlauf retweeted
13 Nov 2023
Congratulations to Adam Steinlauf, MD, for receiving the prestigious 2023 Rosenthal Humanitarian of the Year Award from the Crohn's & Colitis Foundation. Thank you for your incredible contributions to the #IBD community, Dr. Steinlauf. @CrohnsColitisFn @MountSinaiGI #IBDAdvocacy
2
11
2,130
30 Sep 2023
I’m excited to be this years Crohn’s & Colitis Foundation Rosenthal Humanitarian Award recipient. Please join me in supporting this important organization!!
crohnscolitisfoundation.org/…
1
2
5
1,008
12 Aug 2023
Our review article for the @AmCollegeGastro FDA-related Matters Committee.
Overview of biosimilars in inflammatory bowel diseases : Official journal of the American College of Gastroenterology | ACG journals.lww.com/ajg/Abstrac…
5
18
1,580
17 Jul 2023
The CCF is committed to supporting patients and families who suffer from IBD and finding a cure for these diseases. Please join me as this years Humanitarian Award recipient in supporting this great organization. fundraiser.onecause.com/fund…
1
6
923
12 Jun 2023
Dr. Maia Kayal @MaiaKayalMD presents the spectrum of pouchitis at our IBD retreat.
3
6
661
Adam Steinlauf retweeted
As we wrap up a day filled with revealing talks and diverse viewpoints on #IBD, at the center of every discussion was one core message: patient #qualityoflife is always the priority. Thanks to all who presented and attended today's event. Looking forward to next year's course!
2
16
1,274